Literature DB >> 18084881

Gene expression profiles of late colonic Crohn's disease.

Maya D Srivastava1, Mahmoud N Kulaylat.   

Abstract

To determine the genetic program mediating and maintaining the change from susceptibility to Crohn's disease (CD) to ongoing tissue destruction and loss of function, we utilized Affymetrix HG U95 AV2 Gene Chips and analyzed unpooled surgical CD colon specimens from adult patients. Using the patient as his own genetic filter we examined involved versus uninvolved adjacent areas, comparing results within one individual and then performing analysis comparing results between four individuals. Our results interrogated twice as many genes than the previous studies that used pooled unmatched specimens. We identified a limited set of nine genes upregulated in all four patients, and one gene (PTN) as downregulated. Several of the genes, including DEFA6, PAP, REG1A, REG1B, and phospholipase A2 had been implicated in previous studies, supporting their key role in CD. In 3 of 4 patients, 24 genes were upregulated in diseased areas, including DEFA5, IL-8, MMP-1, S100 calcium binding protein, and MGSA. Additional new candidate genes were identified, including DMT1, SERPINA1, GW112, and iNOS. The use of the unpooled samples allowed the detection of significant interindividual differences in expression of many other genes, supporting disease heterogeneity in CD. Results with select genes were confirmed with RT-PCR studies, as well as on biopsy samples from pediatric patients. We have determined a common profile of "late" CD, and also demonstrated the potential variability, suggesting possible differences in etiology, triggers, and the need for more individualized management. Additional studies to investigate protein expression of these candidate genes should be undertaken.

Entities:  

Mesh:

Year:  2004        PMID: 18084881

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  5 in total

Review 1.  Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Elisavet K Tiaka; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2011-01-04       Impact factor: 3.199

2.  Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.

Authors:  Laura Mäkitalo; Taina Sipponen; Päivi Kärkkäinen; Kaija-Leena Kolho; Ulpu Saarialho-Kere
Journal:  Int J Colorectal Dis       Date:  2009-08-04       Impact factor: 2.571

3.  Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling.

Authors:  Trinidad Montero-Meléndez; Xavier Llor; Esther García-Planella; Mauro Perretti; Antonio Suárez
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

4.  Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases.

Authors:  Johanna Born; Alexander Hendricks; Charlotte Hauser; Jan-Hendrik Egberts; Thomas Becker; Christian Röder; Susanne Sebens
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

5.  Divalent metal-ion transporter 1 is decreased in intestinal epithelial cells and contributes to the anemia in inflammatory bowel disease.

Authors:  Wei Wu; Yang Song; Chong He; Changqin Liu; Ruijin Wu; Leilei Fang; Yingzi Cong; Yinglei Miao; Zhanju Liu
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.